Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema

International Journal of Emergency Medicine

Volumn 5, Issue 1, 2012, Pages

  Bernstein, Jonathan A ^a   Moellman, Joseph ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOCAPROIC ACID; BRADYKININ; COMPLEMENT COMPONENT C1S INHIBITOR; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ECALLANTIDE; FRESH FROZEN PLASMA; HISTAMINE; ICATIBANT;

ACE INHIBITOR INDUCED ANGIOEDEMA; ACQUIRED ANGIOEDEMA; ALLERGIC ANGIOEDEMA; ANGIOEDEMA WITH URTICARIAL VASCULITIS; ANGIONEUROTIC EDEMA; BRADYKININ MEDIATED ANGIOEDEMA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HISTAMINE MEDIATED ANGIOEDEMA; HUMAN; IDIOPATHIC ANGIOEDEMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSEUDOALLERGIC ANGIOEDEMA; REVIEW; SUBSTITUTION THERAPY;

EID: 84880132137     PISSN: 18651372     EISSN: 18651380     Source Type: Journal    
DOI: 10.1186/1865-1380-5-39     Document Type: Review

References (43)

1. Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G: Nonallergic angioedema: role of bradykinin. Allergy 2007, 62(8):842-856. (Pubitemid 47037860)
2. Brown SG: Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004, 114(2):371-376.
3. Winters M: Clinical practice guideline: initial evaluation and management of patients presenting with acute urticaria or angioedema. American Academy of Emergency Medicine Web site. http://www.aaem.org/emresources/position- statements/2006/clinical-practice-guidelines. Updated July 10, 2006. Accessed September 14, 2012.
4. Kaplan AP, Ausiello DA: Anaphylaxis. In Cecil Medicine. 23rd edition. Edited by Goldman L. Philadelphia: Saunders; 2008:1450-1452.
5. Kaplan AP, Greaves MW: Angioedema. J Am Acad Dermatol 2005, 53(3):373-388. (Pubitemid 41195957)
6. Flattery MP, Sica DA: Angiotensin-converting enzyme inhibitor-related angioedema: recognition and treatment. Prog Cardiovasc Nurs 2007, 22(Winter):47-51.
7. Weldon D: Differential diagnosis of angioedema. Immunol Allergy Clin North Am. 2006, 26(4):603-613.
8. Frigas E, Park MA: Acute urticaria and angioedema: diagnostic and treatment considerations. Am J Clin Dermatol 2009, 10(4):239-250.
9. Greenberger PA: Anaphylactic and anaphylactoid causes of angioedema. Immunol Allergy Clin North Am 2006, 26(4):753-767.
10. Bork K: Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor. Allergy, Asthma Clin Immunol 2010, 6(1):15.
11. Durham SR: Allergic inflammation: cellular aspects. Allergy 1999, 54(suppl 56):18-20.
12. Nzeako UC, Frigas E, Tremaine WJ: Hereditary angioedema: a broad review for clinicians. Arch Intern Med 2001, 161(20):2417-2429. (Pubitemid 33043115)
13. Epstein TG, Bernstein JA: Current and emerging management options for hereditary angioedema in the US. Drugs 2008, 68(18):2561-2573.
14. Papadopoulou-Alataki E: Upper airway considerations in hereditary angioedema. Curr Opin Allergy Clin Immunol 2010, 10(1):20-25.
15. Jessup M, Brozena S: Heart failure. N Engl J Med 2003, 348(20):2007-2018.
16. Casas JP, Chua W, Loukogeorgakis S, et al: Effect of inhibitors of the reninangiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005, 366(9502):2026-2033. (Pubitemid 41773378)
17. Sánchez-Borges M, González-Aveledo LA: Angiotensin- converting enzyme inhibitors and angioedema. Allergy Asthma Immunol Res 2010, 2:195-198.
18. Donaldson VH, Bernstein DI, Wagner CJ, Mitchell BH, Scinto J, Bernstein IL: Angioneurotic edema with acquired C1- inhibitor deficiency and autoantibody to C1- inhibitor: response to plasmapheresis and cytotoxic therapy. J Lab Clin Med 1992, 119(4):397-406.
19. Bork K, Meng G, Staubach P, Hardt J: Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006, 119(3):267-274. (Pubitemid 43255068)
20. Zuraw BL: Clinical practice. Hereditary angioedema. N Engl J Med 2008, 359(10):1027-1036.
21. Temiño VM, Peebles RS: The spectrum and treatment of angioedema. Am J Med 2008, 121:282-286. (Pubitemid 351417834)
22. Hill MD, Barber PA, Takahashi J, Demchuk AM, Feasby TE, Buchan AM: Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. CMAJ 2000, 162(9):1281-1284. (Pubitemid 30304328)
23. Gompels MM, Lock RJ, Abinun M, et al: C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005, 139(3):379-394. (Pubitemid 40333248)
24. Bowen T, Cicardi M, Farkas H, et al: 2010 international consensus algorithim for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010, 6(24):1-13.
25. Oswalt ML, Kemp SF: Anaphylaxis: office management and prevention. Immunol Allergy Clin North Am 2007, 27(2):177-191. (Pubitemid 46686985)
26. Lin RY, Curry A, Pesola GR, et al: Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med 2000, 36(5):462-468.
27. Bernstein JA: Evaluation of ecallantide for the acute treatment of angiotensin converting enzyme inhibitor induced angioedema (ACE). ClinicalTrials.gov Website. http://clinicaltrials.gov/ct2/show/NCT01036659?term= ecallantide+ACE+inhibitor&rank=1. December 18, 2009. Updated August 17, 2010. Verified March 2012. Accessed September 15, 2012.
28. Technische Universität M: A Melioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study. ClinicalTrials.gov Website. http://clinicaltrials.gov/ct2/show/NCT01154361?term=icatibant+ACE+inhibitor& rank=1. Last updated December 22, 2011. Accessed September 15, 2012.
29. Perez DV, Infante S, Marco G, Zubeldia JM, Marañon G: Angioedema induced by angiotensin-converting enzyme inhibitors: two cases of successful treatment with a novel B2 bradykinin antagonist [AAAAI Abstract]. J Allergy Clin Immunol 2011, 27(2):AB105.
30. Schmidt PW, Hirschl MH, Trautinger F: Case letter: treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant. J Am Acad Dermatol 2010, 63(5):913-914.
31. Bas M, Greve J, Stelter K: Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med 2010, 56(3):278-282.
32. Berinert [package insert]: Kankakee: CSL Behring LLC; 2009.
33. Kalbitor [package insert]: Cambridge: Dyax Corp; 2009.
34. Firazyr [package insert]: Lexington, MA: Shire Orphan Therapies; 2011.
35. Zuraw B: HAE therapies: past present and future. Allergy Asthma Clin Immunol 2010, 6(1):23.
36. Amicar [package insert]: Newport: Xanodyne Pharmaceuticals, Inc; 2008.
37. Bernstein JA: Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies. Ann Allergy Asthma Immunol 2008, 100(1 Suppl 2):S41-6.
38. Banerji A: Current treatment of hereditary angioedema: an update on clinical studies. Allergy Asthma Proc 2010, 31(5):398-406.
39. Lunn M, Banta E: Ecallantide for the treatment of hereditary angiodema in adults. Clin Med Insights Cardiol 2011, 5:49-54.
40. Cruden NLM, Newby DE: Therapeutic potential of icatibant (HOE-140, JE-049). Expert Opin Pharmacother 2008, 9(13):2383-90.
41. Cicardi M, Banerji A, Bracho F, et al: Icatibant, a novel bradykinin B2 receptor antagonist, is effective in the treatment of acute attacks in patients with hereditary angioedema. N Engl J Med 2010, 363(6):532-41.
42. 2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Ann Allergy Asthma Immunol 2011, 107(6):529-537.
43. Bowen T, Cicardi M, Bork K, et al: Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol 2008, 100(1 Suppl 2):S30-40.